To explore the clinical relevance of GABRP in pancreatic cancer patients, we took advantage of starBase V3.0 (http://starbase.sysu.edu.cn/) (Li et al., 2013) where 178 cancer and four normal samples were analyzed in pancreatic adenocarcinoma (PAAD). Here, GABRP is linked to pancreatic adenocarcinoma.